title: Characterization of patients with dystrophic epidermolysis bullosa for collagen VII therapy.
authors.affiliation: Department of Dermatology, Stanford School of Medicine, Stanford, CA, U.S.A.
authors.forename: E S
authors.initials: ES
authors.lastname: Gorell
authors.affiliation: Department of Dermatology, Stanford School of Medicine, Stanford, CA, U.S.A.
authors.forename: N
authors.initials: N
authors.lastname: Nguyen
authors.affiliation: Department of Dermatology, Stanford School of Medicine, Stanford, CA, U.S.A.
authors.forename: Z
authors.initials: Z
authors.lastname: Siprashvili
authors.affiliation: Department of Dermatology, Stanford School of Medicine, Stanford, CA, U.S.A.|Dermatology Service, VA Palo Alto Medical Center, Palo Alto, CA, U.S.A.
authors.forename: M P
authors.initials: MP
authors.lastname: Marinkovich
authors.affiliation: Department of Dermatology, Stanford School of Medicine, Stanford, CA, U.S.A.
authors.forename: A T
authors.initials: AT
authors.lastname: Lane
mesh_terms: D024143:Collagen Type VII / Q000235:genetics / Q000627:therapeutic use*; D004797:Enzyme-Linked Immunosorbent Assay; D016108:Epidermolysis Bullosa Dystrophica / Q000188:drug therapy* / Q000235:genetics; D006801:Humans; D009154:Mutation / Q000235:genetics*; D018579:Patient Selection
chemical_list: C569053:COL7A1 protein, human; D024143:Collagen Type VII